Genmab A/S
GMAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $482 | $2,681 | $1,658 | $445 |
| Dep. & Amort. | $18 | $101 | $109 | $13 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34 | $209 | $170 | $20 |
| Change in WC | $2 | -$665 | $510 | $16 |
| Other Non-Cash | $0 | -$1,933 | -$496 | -$168 |
| Operating Cash Flow | $536 | $393 | $1,950 | $326 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$63 | -$82 | -$12 |
| Net Acquisitions | $0 | $0 | $0 | $126 |
| Inv. Purchases | -$387 | -$1,901 | -$1,848 | -$132 |
| Inv. Sales/Matur. | $335 | $2,129 | $1,760 | $147 |
| Other Inv. Act. | $0 | $0 | -$122 | -$15 |
| Investing Cash Flow | -$54 | $165 | -$292 | $114 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$25 | -$14 | $1 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$24 | -$2,573 | -$562 | $40 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8 | $25 | $488 | $0 |
| Financing Cash Flow | -$21 | -$2,573 | -$88 | $41 |
| Forex Effect | $4 | -$32 | $54 | -$56 |
| Net Chg. in Cash | $465 | -$2,047 | $1,624 | $425 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,296 | $10,260 | $9,376 | $950 |
| End Cash | $1,761 | $8,213 | $11,000 | $1,375 |
| Free Cash Flow | $534 | $330 | $1,746 | $299 |